<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tan Y</submitter><funding>National Natural Science Foundation of China</funding><pagination>1149810</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10076825</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Patients with diabetes mellitus (DM) have a higher incidence of malignant tumors than people without diabetes, but the underlying molecular mechanisms are still unclear.&lt;h4>Methods&lt;/h4>To investigate the link between DM and cancer, we screened publicly available databases for diabetes and cancer-related genes (DCRGs) and constructed a diabetes-based cancer-associated inflammation network (DCIN). We integrated seven DCRGs into the DCIN and analyzed their role in different tumors from various perspectives. We also investigated drug sensitivity and single-cell sequencing data in colon adenocarcinoma as an example. In addition, we performed &lt;i>in vitro&lt;/i> experiments to verify the expression of DCRGs and the arachidonic acid metabolic pathway.&lt;h4>Results&lt;/h4>Seven identifie</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Diabetes mellitus induces a novel inflammatory network involving cancer progression: Insights from bioinformatic analysis and &lt;i>in vitro&lt;/i> validation.</pubmed_title><pmcid>PMC10076825</pmcid><funding_grant_id>81873169</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Zhong A</pubmed_authors><pubmed_authors>Peng W</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Tan Y</pubmed_authors><pubmed_authors>Kang J</pubmed_authors><pubmed_authors>Huang R</pubmed_authors><pubmed_authors>Cheng X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diabetes mellitus induces a novel inflammatory network involving cancer progression: Insights from bioinformatic analysis and &lt;i>in vitro&lt;/i> validation.</name><description>&lt;h4>Background&lt;/h4>Patients with diabetes mellitus (DM) have a higher incidence of malignant tumors than people without diabetes, but the underlying molecular mechanisms are still unclear.&lt;h4>Methods&lt;/h4>To investigate the link between DM and cancer, we screened publicly available databases for diabetes and cancer-related genes (DCRGs) and constructed a diabetes-based cancer-associated inflammation network (DCIN). We integrated seven DCRGs into the DCIN and analyzed their role in different tumors from various perspectives. We also investigated drug sensitivity and single-cell sequencing data in colon adenocarcinoma as an example. In addition, we performed &lt;i>in vitro&lt;/i> experiments to verify the expression of DCRGs and the arachidonic acid metabolic pathway.&lt;h4>Results&lt;/h4>Seven identifie</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-06-27T03:24:51.565Z</modification><creation>2025-02-19T01:32:43.064Z</creation></dates><accession>S-EPMC10076825</accession><cross_references><pubmed>37033970</pubmed><doi>10.3389/fimmu.2023.1149810</doi></cross_references></HashMap>